← Back to Clinical Trials
Recruiting NCT06602440

NCT06602440 Effect of Epidural Catheter Retention Depth on Labor Analgesia Performed in DPE Combined With PIEB Model

◆ AI Clinical Summary
Plain-language summary for patients
Clinical Trial Summary
NCT ID NCT06602440
Status Recruiting
Phase
Sponsor General Hospital of Ningxia Medical University
Condition Labor Analgesia
Study Type INTERVENTIONAL
Enrollment 102 participants
Start Date 2024-07-01
Primary Completion 2024-10-01

Eligibility & Interventions

Sex Female only
Min Age 18 Years
Max Age 45 Years
Study Type INTERVENTIONAL
Interventions
The indwelling length of epidural catheter is 3 centimeters.The indwelling length of epidural catheter is 5 centimeters.The indwelling length of epidural catheter is 7 centimeters.

Eligibility Fast-Check

Enter your details for a quick preliminary check. This does not replace medical advice.

What to Expect as a Participant

You will actively receive the study intervention — which may be a drug, biologic, device, or procedure.

This trial targets 102 participants in total. It began in 2024-07-01 with a primary completion date of 2024-10-01.

⚠ This information is for research awareness only. Always consult your physician before joining any clinical trial. Participation is voluntary and you may withdraw at any time.

Brief Summary

The purpose of this study is to observe the appropriate indwelling depth of epidural catheter when labor analgesia is performed in the mode of DPE combined with PIEB, and then shorten the onset time of labor analgesia and reduce the occurrence of catheter-related adverse outcomes.

Eligibility Criteria

Inclusion Criteria: 1. Those aged 18 to 45 years old; 2. Pregnancy lasts for 37 to 42 weeks; 3. Single healthy pregnant women with cervical dilation \< 3.0 cm who wish to use epidural labor analgesia; 4. The NRS score of uterine contraction pain is \> 3; 5. ASA grade I-II; 6. BMI ≤ 40 kg/m². Exclusion Criteria: 1. Those with contraindications to intraspinal anesthesia; 2. Those with a history of allergy to local anesthetics and opioids; 3. Pregnancy diseases (such as pregnancy-induced hypertension, preeclampsia or gestational diabetes, etc.); 4. Known fetal abnormalities or situations associated with an increased risk of cesarean section; 5. Patients who have taken opioids or sedatives within 4 hours before epidural analgesia.

Contact & Investigator

Central Contact

xinli Ni, MD

✉ xinlini6@nyfy.com.cn

📞 13909586966

Frequently Asked Questions

Who can join the NCT06602440 clinical trial?

This trial is open to female participants only, aged 18 Years or older, up to 45 Years, studying Labor Analgesia. Full inclusion and exclusion criteria are listed in the Eligibility Criteria section. Always confirm your eligibility with the research team before applying.

Is NCT06602440 currently recruiting?

Yes, NCT06602440 is actively recruiting participants. Contact the research team at xinlini6@nyfy.com.cn for enrollment information.

Where is the NCT06602440 trial being conducted?

This trial is being conducted at Yinchuan, China.

Who is sponsoring the NCT06602440 clinical trial?

NCT06602440 is sponsored by General Hospital of Ningxia Medical University. The trial plans to enroll 102 participants.

Related Trials

ClinicalMetric — Independent clinical trial intelligence platform. Not affiliated with NIH, ClinicalTrials.gov, the U.S. FDA, or any pharmaceutical company, hospital, or clinical research organization. Trial data is sourced from ClinicalTrials.gov for informational purposes only and does not constitute medical advice. Do not make any treatment, enrollment, or health decisions based solely on information found here — always consult a qualified healthcare professional. Full Disclaimer  ·  Last Reviewed: July 2026  ·  Data Methodology